Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

GAO Recommends Wider Look at Opioid Use by Medicare Beneficiaries

  • Post author:Sam
  • Post published:November 7, 2017
  • Post category:Drug Industry Daily

Federal administrators of the Medicare Part D prescription-drug program should expand their oversight of opioid prescriptions and focus their surveillance of potential drug abuse more tightly on opioids, the U.S.…

Continue ReadingGAO Recommends Wider Look at Opioid Use by Medicare Beneficiaries

Republicans, Democrats Gang Up on Allergan at U.S. House Hearing

  • Post author:Sam
  • Post published:November 7, 2017
  • Post category:Drug Industry Daily

Allergan drew bipartisan fire from U.S. House members considering issues raised by the company’s innovative scheme to shield its patents on the blockbuster dry-eye drug Restasis from challenges before the…

Continue ReadingRepublicans, Democrats Gang Up on Allergan at U.S. House Hearing

POTUS Already Has Power DoD Seeks in Controversial Drug Proposal, Professor Says

  • Post author:Sam
  • Post published:November 7, 2017
  • Post category:Drug Industry Daily

A Stanford law professor said the president already has the authority to provide for administration of unapproved drugs to military personnel — a power similar to that proposed for the…

Continue ReadingPOTUS Already Has Power DoD Seeks in Controversial Drug Proposal, Professor Says

Roche Lays Off 235 Employees in Switzerland

  • Post author:Sam
  • Post published:November 6, 2017
  • Post category:BioPharma

The jobs are being cut because Roche is moving Swiss packaging ops to CMO-divested sites. Source: BioSpace

Continue ReadingRoche Lays Off 235 Employees in Switzerland

Massachusetts' Haemonetics to Eliminate 350 Jobs

  • Post author:Sam
  • Post published:November 6, 2017
  • Post category:BioPharma

Shares of Haemonetics are up nearly 10 percent this morning after the company announced it was cutting about 11 percent of its workforce in a restructuring effort. Source: BioSpace

Continue ReadingMassachusetts' Haemonetics to Eliminate 350 Jobs

The Lone 3 Big Pharmas That Will Gain Market Share Over the Next Few Years

  • Post author:Sam
  • Post published:November 6, 2017
  • Post category:BioPharma

With worldwide spending on prescription drugs increasing from an estimated $774B in 2017 to over $1 trillion in 2022, a rising tide of pharmaceutical sales is lifting a lot of…

Continue ReadingThe Lone 3 Big Pharmas That Will Gain Market Share Over the Next Few Years

AI Takes Off in Biotech, Creating Demand for High Paying Jobs of $500K Plus

  • Post author:Sam
  • Post published:November 6, 2017
  • Post category:BioPharma

Salaries and total compensation can range from $300,000 to $500,000 per year for these employees – whether they have a Ph.D. or are just out of college. Source: BioSpace

Continue ReadingAI Takes Off in Biotech, Creating Demand for High Paying Jobs of $500K Plus

Senator Harris Scrutinizes How Alkermes Pushed Its Opioid Addiction Drug

  • Post author:Sam
  • Post published:November 6, 2017
  • Post category:BioPharma

Harris fired the first shots on Monday. Source: BioSpace

Continue ReadingSenator Harris Scrutinizes How Alkermes Pushed Its Opioid Addiction Drug

Takeda, Portal Instruments Ink $100M Deal to Develop Needle-Free Drug Delivery Device

  • Post author:Sam
  • Post published:November 6, 2017
  • Post category:BioPharma

Takeda inked a collaboration deal to develop and commercialize Portal's needle-free drug delivery device for use with some of Takeda's biologic medicines. Source: BioSpace

Continue ReadingTakeda, Portal Instruments Ink $100M Deal to Develop Needle-Free Drug Delivery Device

Confident Bristol-Myers to Launch 700-Patient Phase III IDO Trial for Melanoma

  • Post author:Sam
  • Post published:November 6, 2017
  • Post category:BioPharma

Bristol-Myers is initiating a Phase III clinical trial of BMS-986205 with nivolumab in patients with advanced melanoma. Source: BioSpace

Continue ReadingConfident Bristol-Myers to Launch 700-Patient Phase III IDO Trial for Melanoma
  • Go to the previous page
  • 1
  • …
  • 266
  • 267
  • 268
  • 269
  • 270
  • 271
  • 272
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.